In health innovation, momentum isn’t the challenge; precision is. At a certain stage, healthtech leaders find that what once worked no longer scales. Revenue plateaus, GTM efforts diverge, and the market narrative becomes less clear.
It’s not a lack of effort; it’s a lack of strategic cohesion.
That’s exactly what our Strategic Growth Consulting restores. We partner with growth-stage and PE-backed leaders to realign strategy, narrative, and execution, so every commercial lever drives measurable enterprise value.
Our team can help you identify the gaps between traction, valuation, and scalability and define your next phase of expansion.
Book a strategic growth review
Once you establish product market fit, the next barrier isn’t validation; it’s alignment.
You’ve proven the model. You have clinical validation, regulatory clearance, and paying customers. Yet the growth curve stalls, and the valuation story doesn’t fully reflect the potential.
Across the health innovation landscape, we see the same friction points:
Strategic growth isn’t about louder marketing or bigger sales budgets. It’s about defining, operationalizing, and aligning your growth narrative across every touchpoint that drives valuation.
That’s the foundation of how we help health innovators scale.
We anchor our framework in three core growth programs from our strategic foundation:
We start by diagnosing where clarity breaks down across market perception, buyer journey, and internal alignment. Through structured research and stakeholder analysis, we identify the growth levers most directly tied to enterprise value.
This include:
Once your foundation is defined, we refine how that value translates to the market and the boardroom.
Our valuation-driven positioning process ensures your commercial story aligns with investor logic and buyer impact.
We help you:
Finally, we operationalize your strategy. That means translating insights into motion and embedding the strategy into your GTM engine so teams can execute with precision and speed.
We guide you through:
When you bring these three elements together, foundation, positioning, and acceleration, you don’t just grow revenue. You grow valuation, investor confidence, and market momentum simultaneously.
Turn clarity into commercial momentum
At Legacy DNA, growth consulting isn’t about adding layers of complexity; it’s about stripping away what’s slowing you down.
Our Strategic Growth Framework helps leadership teams identify, prioritize, and activate the levers that directly impact scale.
We analyze the intersection between your market position, buyer evolution, and growth potential. This includes sizing expansion opportunities, mapping adjacent markets, and uncovering unmet value pools
The outcome: a clear, data-backed growth thesis that aligns commercial execution with investor expectations.
We ensure your story moves seamlessly from the boardroom to the buyer. Your investor narrative, product positioning, and go-to-market messaging should reinforce each other rather than compete for attention.
We operationalize messaging consistency so that your leadership, sales, and marketing teams speak with one voice, one that moves markets, not just minds.
Growth requires precision execution.
We work with your commercial leaders to translate strategy into repeatable systems, refining target segmentation, channel prioritization, and customer journey activation.
That means faster sales cycles, more efficient marketing spend, and measurable ROI.
For multi-asset or PE-backed organizations, growth requires cohesion at scale.
We develop frameworks that create alignment across the portfolio, ensuring each brand or business unit aligns with a unified enterprise value story.
This portfolio-level clarity reduces friction, accelerates decision-making, and unlocks higher valuation multiples across your holdings.
Legacy DNA partnered with BioPlus Specialty Pharmacy to refine brand consistency, refresh market positioning, and strengthen go-to-market execution. The results: a 2x increase in revenue and a 202% increase in gross profit, with the company recognized as one of the nation’s top specialty pharmacies.
“Roxie and her team brought a freshness and consistency to our brand that transformed our performance. It’s had a tremendous impact.” — Dr. Steve Vogt, Founder & CEO, BioPlus Specialty Pharmacy.
Health innovation moves fast, and so do we. Our team helps you turn strategic clarity into measurable outcomes that scale.
If your organization has hit the “complexity ceiling” with strong traction but slowed momentum, it’s time for a deeper look.
We’ll help you:
Request a growth acceleration diagnostic
